Cargando…

Manganese-Induced Parkinsonism due to Ephedrone Abuse

During recent years, a syndrome of hypokinesia, dysarthria, dystonia, and postural impairment, related to intravenous use of a “designer” psychostimulant derived from pseudoephedrine using potassium permanganate as the oxidant, has been observed in drug addicts in several countries in Eastern Europe...

Descripción completa

Detalles Bibliográficos
Autores principales:	Sikk, Katrin, Haldre, Sulev, Aquilonius, Sten-Magnus, Taba, Pille
Formato:	Texto
Lenguaje:	English
Publicado:	SAGE-Hindawi Access to Research 2011
Materias:	Review Article
Acceso en línea:	https://www.ncbi.nlm.nih.gov/pmc/articles/PMC3043321/ https://www.ncbi.nlm.nih.gov/pubmed/21403909 http://dx.doi.org/10.4061/2011/865319

Ejemplares similares

Peripheral Blood RNA Expression Profiling in Illicit Methcathinone Users Reveals Effect on Immune System
por: Sikk, Katrin, et al.
Publicado: (2011)

Manganese toxicity with ephedrone abuse manifesting as parkinsonism: a case report
por: Iqbal, Mudassir, et al.
Publicado: (2012)

Eye Movements in Ephedrone-Induced Parkinsonism
por: Bonnet, Cecilia, et al.
Publicado: (2014)

MRI brain findings in ephedrone encephalopathy associated with manganese abuse: Single-center perspective
por: Poniatowska, Renata, et al.
Publicado: (2014)

Manganese Encephalopathy Caused by Homemade Methcathinone (Ephedrone) Prevalence in Poland
por: Habrat, Bogusław, et al.
Publicado: (2021)

Development of new levodopa treatment strategies in Parkinson’s disease—from bedside to bench to bedside
por: Aquilonius, Sten-Magnus, et al.
Publicado: (2017)

Subacute administration of both methcathinone and manganese causes basal ganglia damage in mice resembling that in methcathinone abusers
por: Asser, Andres, et al.
Publicado: (2019)

Acute effects of methcathinone and manganese in mice: A dose response study
por: Asser, Andres, et al.
Publicado: (2019)

Looking beyond the brain to improve the pathogenic understanding of Parkinson’s disease: implications of whole transcriptome profiling of Patients’ skin
por: Planken, Anu, et al.
Publicado: (2017)

Crystal structures and other properties of ephedrone (methcathinone) hydrochloride, N-acetylephedrine and N-acetylephedrone
por: Kuś, Piotr, et al.
Publicado: (2018)

Factors associated with motor complications in Parkinson's disease
por: Kadastik‐Eerme, Liis, et al.
Publicado: (2017)

Serum Amyloid Alpha Is Downregulated in Peripheral Tissues of Parkinson’s Disease Patients
por: Kurvits, Lille, et al.
Publicado: (2019)

Nonmotor Features in Parkinson's Disease: What Are the Most Important Associated Factors?
por: Kadastik-Eerme, Liis, et al.
Publicado: (2016)

Validation of an Estonian version of the Parkinson's Disease Questionnaire (PDQ-39)
por: Krikmann, Ülle, et al.
Publicado: (2008)

Changes in the Peripheral Blood Gene Expression Profile Induced by 3 Months of Valproate Treatment in Patients with Newly Diagnosed Epilepsy
por: Rakitin, Aleksei, et al.
Publicado: (2015)

Manganese-Induced Parkinsonism and Parkinson’s Disease: Shared and Distinguishable Features
por: Kwakye, Gunnar F., et al.
Publicado: (2015)

Structured guideline-based physiotherapy reduces difficulties in activities of daily living in Parkinson’s disease
por: Medijainen, Kadri, et al.
Publicado: (2022)

Versatile guideline-based physiotherapy intervention in groups to improve gait speed in Parkinson’s disease patients
por: Medijainen, Kadri, et al.
Publicado: (2019)

Dissociation of reward and effort sensitivity in methcathinone‐induced Parkinsonism
por: Chong, Trevor T.‐J., et al.
Publicado: (2017)

Functional Performance and Associations between Performance Tests and Neurological Assessment Differ in Men and Women with Parkinson's Disease
por: Medijainen, Kadri, et al.
Publicado: (2015)

Parkinson’s Disease and Symptomatic Osteoarthritis Are Independent Risk Factors of Falls in the Elderly
por: Teder-Braschinsky, Anneli, et al.
Publicado: (2019)

(123)I-ADAM SPET imaging of serotonin transporter in patients with epilepsy and comorbid depression
por: Liik, Maarika, et al.
Publicado: (2013)

Analysis of repetitive element expression in the blood and skin of patients with Parkinson’s disease identifies differential expression of satellite elements
por: Billingsley, Kimberley J., et al.
Publicado: (2019)

Comparison of the Metabolic Syndrome Risk in Valproate-Treated Patients with Epilepsy and the General Population in Estonia
por: Rakitin, Aleksei, et al.
Publicado: (2014)

Peripheral blood RNA gene expression profiling in patients with bacterial meningitis
por: Lill, Margit, et al.
Publicado: (2013)

Manganese-Induced Parkinsonism: Evidence from Epidemiological and Experimental Studies
por: Lucchini, Roberto, et al.
Publicado: (2023)

Health-related quality of life in Parkinson’s disease: a cross-sectional study focusing on non-motor symptoms
por: Kadastik-Eerme, Liis, et al.
Publicado: (2015)

Manganese induced parkinsonism: a case report.
por: Kim, J. W., et al.
Publicado: (1998)

Increased Serum Levels of Mesencephalic Astrocyte-Derived Neurotrophic Factor in Subjects With Parkinson’s Disease
por: Galli, Emilia, et al.
Publicado: (2019)

Psychostimulants and Movement Disorders
por: Asser, Andres, et al.
Publicado: (2015)

Levodopa/carbidopa microtablets in Parkinson’s disease: a study of pharmacokinetics and blinded motor assessment
por: Senek, Marina, et al.
Publicado: (2017)

Grey matter abnormalities in methcathinone abusers with a Parkinsonian syndrome
por: Juurmaa, Julius, et al.
Publicado: (2016)

Ethnic Identity in Transition: the Potential Impact of Ethnicity on Chronic Illness’ Medication Adherence in Post-Soviet Country
por: Lubi, Kadi, et al.
Publicado: (2021)

Manganese and Parkinson’s Disease: A Critical Review and New Findings
por: Guilarte, Tomás R.
Publicado: (2010)

New Insights on the Role of Manganese in Alzheimer’s Disease and Parkinson’s Disease
por: Martins, Airton Cunha, et al.
Publicado: (2019)

Neurosyphilis as a great imitator: a case report
por: Sabre, Liis, et al.
Publicado: (2016)

Education on palliative care for Parkinson patients: development of the “Best care for people with late-stage Parkinson’s disease” curriculum toolkit
por: Gatsios, Dimitrios, et al.
Publicado: (2021)

Creutzfeldt-Jakob Disease Presenting as Nonconvulsive Status Epilepticus
por: Rakitin, Aleksei, et al.
Publicado: (2018)

Manganese Inhalation as a Parkinson Disease Model
por: Ordoñez-Librado, José Luis, et al.
Publicado: (2010)

Manganese‐induced parkinsonism responsive to intranasal insulin: A case report
por: Salari, Mehri, et al.
Publicado: (2022)

Cannot write session to /tmp/vufind_sessions/sess_o6ojts04mlmj1tbso2a7cem7ba